“There are a lot of non-responders with CRT. Thirty-two to fifty percent of patients do not respond. It means you are performing a very long surgery, and the patient may still not answer at the end of the day,” said Chloe Audigier, a researcher at Siemens. “A technology like this could save time for the radiologist and for the patient by allowing you to predict if the therapy would work. The more you can predict that, the chance of a patient not responding, the more efficient you can be with it.”

Though launched by Microsoft in February, commercialization of HoloLens 2 is not expected to begin until the fall of 2019. Digital Twin, meanwhile, is a concept of a potential capabilities that Siemens is only examining at this time, with no concrete plans as of yet to develop and commercialize it as a finalized product.

For spectators like Lauren Kennedy, a fourth-year radiography student at University College Dublin, however, the chance to see these technologies up close is an exciting look at what the future potentially holds for her profession and healthcare as a whole.

“There are so many people coming in and out, just having a look,” she told HCB News. “The hall is really promoting the potential for AI and digitalization not just here but everywhere, because now people are going to go back to their own countries and relaying what they have seen.”

Back to HCB News

European News Homepage